Suppr超能文献

骨保护素可抑制华法林和维生素D诱导的动脉钙化。

Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.

作者信息

Price P A, June H H, Buckley J R, Williamson M K

机构信息

Division of Biology, University of California, San Diego, La Jolla, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1610-6. doi: 10.1161/hq1001.097102.

Abstract

The present experiments were carried out to test the hypothesis that arterial calcification is linked to bone resorption by determining whether the selective inhibition of bone resorption with osteoprotegerin will inhibit arterial calcification. In the first test, arterial calcification was induced by treating 22-day-old male rats with warfarin, a procedure that inhibits the gamma-carboxylation of matrix Gla protein and causes extensive calcification of the arterial media. Compared with rats treated for 1 week with warfarin alone, rats treated with warfarin plus osteoprotegerin at a dose of 1 mg/kg per day had dramatically reduced alizarin red staining for calcification in the aorta and in the carotid, hepatic, mesenteric, renal, and femoral arteries, and they had 90% lower levels of calcium and phosphate in the abdominal aorta (P<0.001) and in tracheal ring cartilage (P<0.01). More rapid arterial calcification was induced by treating 49-day-old male rats with toxic doses of vitamin D. Treatment for 96 hours with vitamin D caused widespread alizarin red staining for calcification in the aorta and the femoral, mesenteric, hepatic, renal, and carotid arteries, and osteoprotegerin completely prevented calcification in each of these arteries and reduced the levels of calcium and phosphate in the abdominal aorta to control levels (P<0.001). Treatment with vitamin D also caused extensive calcification in the lungs, trachea, kidneys, stomach, and small intestine, and treatment with osteoprotegerin reduced or prevented calcification in each of these sites. Measurement of serum levels of cross-linked N-teleopeptides showed that osteoprotegerin dramatically reduced bone resorption activity in each of these experiments (P<0.001). Therefore, we conclude that doses of osteoprotegerin that inhibit bone resorption are able to potently inhibit the calcification of arteries that is induced by warfarin treatment and by vitamin D treatment. These results support the hypothesis that arterial calcification is linked to bone resorption.

摘要

进行本实验以检验以下假设

通过确定用骨保护素选择性抑制骨吸收是否会抑制动脉钙化,来验证动脉钙化与骨吸收有关。在第一个试验中,用华法林处理22日龄雄性大鼠以诱导动脉钙化,该处理会抑制基质Gla蛋白的γ-羧化并导致动脉中层广泛钙化。与仅用华法林处理1周的大鼠相比,每天以1mg/kg的剂量用华法林加骨保护素处理的大鼠,其主动脉、颈动脉、肝动脉、肠系膜动脉、肾动脉和股动脉中钙化的茜素红染色显著减少,并且其腹主动脉(P<0.001)和气管环软骨(P<0.01)中的钙和磷水平降低了90%。用毒性剂量的维生素D处理49日龄雄性大鼠可诱导更快的动脉钙化。用维生素D处理96小时会导致主动脉、股动脉、肠系膜动脉、肝动脉、肾动脉和颈动脉中出现广泛的钙化茜素红染色,而骨保护素完全阻止了这些动脉中的钙化,并将腹主动脉中的钙和磷水平降低至对照水平(P<0.001)。用维生素D处理还会导致肺、气管、肾、胃和小肠广泛钙化,而用骨保护素处理可减少或阻止这些部位的钙化。交联N-端肽血清水平的测量表明,在每个实验中骨保护素都显著降低了骨吸收活性(P<0.001)。因此,我们得出结论,抑制骨吸收的骨保护素剂量能够有效抑制由华法林处理和维生素D处理诱导的动脉钙化。这些结果支持了动脉钙化与骨吸收有关的假设。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验